TGF beta peptide antagonists (Auxagen)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameTGF beta peptide antagonists (Auxagen)
Drug Alias NameTGF beta peptantagonists (Auxagen)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTransforming growth factor beta receptors antagonists
TargetsTransforming growth factor beta receptors
Therapy Area/IndicationsDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAuxagen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAuxagen Inc
Active IndicationsN/A
Inactive IndicationsDiabetic Foot

Other Information

ATC CodeN/A
Related LinksN/A